K. Peter R. Nilsson

K. Peter R. Nilsson

Auto-generated profile, based on publicly available information

K. Peter R. Nilsson

Department of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2009 in ACS Chemical Biology
Verified
Journal Article
Closed access
AÅAndreas Åslund
Andreas Åslund
CSChristina J. Sigurdson
Christina J. Sigurdson
TKTherése Klingstedt
Therése Klingstedt
SGStefan Grathwohl
Stefan Grathwohl
TBTristan Bolmont
Tristan Bolmont
KNK. Peter R. Nilsson
K. Peter R. Nilsson


23 September 2011 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
TKTherése Klingstedt
Therése Klingstedt
AÅAndreas Åslund
Andreas Åslund
RSRozalyn A. Simon
Rozalyn A. Simon
LJLeif B. G. Johansson
Leif B. G. Johansson
JMJeffrey J. Mason
Jeffrey J. Mason
KNK. Peter R. Nilsson
K. Peter R. Nilsson
Molecular probes for selective identification of protein aggregates are important to advance our understanding of the molecular pathogenesis underlying protein aggregation diseases. Here we report the chemical design of a library of anionic luminescent conjugated oligothiophenes (LCOs), which can be utilized as ligands for detection of protein aggregates. Certain molecular requirements were shown to be necessary for detecting (i) early non-thioflavinophilic protein assemblies of Aβ1-42 and insulin preceding the formation of amyloid fibrils and (ii) for obtaining distinct spectral signatures of the two main pathological hallmarks observed in human Alzheimer's diease brain tissue (Aβ plaques and neurofibrillary tangles). Our findings suggest that a superior anionic LCO-based ligand should have a backbone consisting of five to seven thiophene units and carboxyl groups extending the conjugated thiophene backbone. Such LCOs will be highly useful for studying the underlying molecular events of protein aggregation diseases and could also be utilized for the development of novel diagnostic tools for these diseases.

10 February 2005 in Biochemistry
Verified
Journal Article
Closed access
KNK. Peter R. Nilsson
K. Peter R. Nilsson
AHAnna Herland
Anna Herland
PHPer Hammarstrom
Per Hammarstrom
OIOlle Inganäs
Olle Inganäs

19 August 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
KNK. Peter R. Nilsson
K. Peter R. Nilsson
JRJohan Rydberg
Johan Rydberg
LBLars Baltzer
Lars Baltzer
OIOlle Inganäs
Olle Inganäs
The optical transitions of a chiral, three-substituted polythiophene with an amino acid function can be tuned by interactions with synthetic peptides. The addition of a positively charged peptide with a random-coil formation will force the polymer to adopt a nonplanar conformation, and the intensity of the emitted light is increased and blue-shifted. After the addition of a negatively charged peptide with a random-coil conformation, the backbone of the polymer adopts a planar conformation and an aggregation of the polymer chains occurs, seen as a red shift and a decrease of the intensity of the emitted light. By adding the positively charged peptide designed to form a four-helix bundle with the negatively charged peptide, the polymer aggregates are disrupted and the intensity of the emitted light is increased because of separation of the polymer chains. This technique could be used as a platform for making novel sensors and biomolecular switches.

18 June 2013 in Chemistry – A European Journal
Verified
Journal Article
Open access
PDF file
TKTherése Klingstedt
Therése Klingstedt
HSHamid Shirani
Hamid Shirani
KÅK. O. Andreas Åslund
K. O. Andreas Åslund
NCNigel J. Cairns
Nigel J. Cairns
CSChristina J. Sigurdson
Christina J. Sigurdson
KNK. Peter R. Nilsson
K. Peter R. Nilsson
Protein misfolding diseases are characterized by deposition of protein aggregates, and optical ligands for molecular characterization of these disease‐associated structures are important for understanding their potential role in the pathogenesis of the disease. Luminescent conjugated oligothiophenes (LCOs) have proven useful for optical identification of a broader subset of disease‐associated protein aggregates than conventional ligands, such as thioflavin T and Congo red. Herein, the molecular requirements for achieving LCOs able to detect nonthioflavinophilic Aβ aggregates or non‐congophilic prion aggregates, as well as spectrally discriminate Aβ and tau aggregates, were investigated. An anionic pentameric LCO was subjected to chemical engineering by: 1) replacing thiophene units with selenophene or phenylene moieties, or 2) alternating the anionic substituents along the thiophene backbone. In addition, two asymmetric tetrameric ligands were generated. Overall, the results from this study identified conformational freedom and extended conjugation of the conjugated backbone as crucial determinants for obtaining superior thiophene‐based optical ligands for sensitive detection and spectral assignment of disease‐associated protein aggregates.